Opaleye Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $9.83M | Sell |
|
|||||
|
2023
Q4 | $10.9M | Sell |
|
|||||
|
2023
Q3 | $11M | Sell |
|
|||||
|
2023
Q2 | $15.2M | Buy |
|
|||||
|
2023
Q1 | $12.6M | Buy |
|
|||||
|
2022
Q4 | $13.4M | Buy |
|
|||||
|
2022
Q3 | $13.2M | Hold |
|
|||||
|
2022
Q2 | $12.5M | Sell |
|
|||||
|
2022
Q1 | $15.2M | Sell |
|
|||||
|
2021
Q4 | $20.6M | Buy |
|
|||||
|
2021
Q3 | $8.46M | Buy |
|
|||||
|
2021
Q2 | $3.78M | Buy |
|
|||||
|
2021
Q1 | $2.87M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $3.76M | Sell |
|
|||||
|
2020
Q2 | $7.63M | Buy |
|
|||||
|
2020
Q1 | $5.42M | Buy |
|
|||||
|
2019
Q4 | $6.68M | Buy |
|
|||||
|
2019
Q3 | $3.11M | Buy |
|
|||||
|
2019
Q2 | $900K | Sell |
|
|||||
|
2019
Q1 | $1.66M | Buy |
|